AU2002354460A1 - Medicinal composition - Google Patents

Medicinal composition

Info

Publication number
AU2002354460A1
AU2002354460A1 AU2002354460A AU2002354460A AU2002354460A1 AU 2002354460 A1 AU2002354460 A1 AU 2002354460A1 AU 2002354460 A AU2002354460 A AU 2002354460A AU 2002354460 A AU2002354460 A AU 2002354460A AU 2002354460 A1 AU2002354460 A1 AU 2002354460A1
Authority
AU
Australia
Prior art keywords
medicinal composition
medicinal
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002354460A
Inventor
Shinichi Kurakata
Tomoyuki Shibata
Naomi Shimazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of AU2002354460A1 publication Critical patent/AU2002354460A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU2002354460A 2001-12-11 2002-12-10 Medicinal composition Abandoned AU2002354460A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001-376954 2001-12-11
JP2001376954 2001-12-11
PCT/JP2002/012939 WO2003053440A1 (en) 2001-12-11 2002-12-10 Medicinal composition

Publications (1)

Publication Number Publication Date
AU2002354460A1 true AU2002354460A1 (en) 2003-07-09

Family

ID=19185039

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002354460A Abandoned AU2002354460A1 (en) 2001-12-11 2002-12-10 Medicinal composition

Country Status (3)

Country Link
AU (1) AU2002354460A1 (en)
TW (1) TW200300677A (en)
WO (1) WO2003053440A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2580973C (en) 2004-09-28 2012-03-06 Sankyo Company Limited Intermediate of 6-substituted 1-methyl-1-h-benzimidazole derivative and method for producing same
JP5133071B2 (en) * 2006-02-09 2013-01-30 第一三共株式会社 Anticancer pharmaceutical composition
TW201336497A (en) * 2007-02-08 2013-09-16 Daiichi Sankyo Co Ltd Crystalline forms of a thiazolidinedione compound and manufacturing methods thereof
JPWO2010013769A1 (en) 2008-07-31 2012-01-12 第一三共株式会社 Crystal of thiazolidinedione compound and method for producing the same
EP2305673A4 (en) 2008-07-31 2011-11-02 Daiichi Sankyo Co Ltd Crystal of thiazolidinedione compound, and process for production thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994015901A1 (en) * 1993-01-11 1994-07-21 Ligand Pharmaceuticals Inc. Compounds having selectivity for retinoid x receptors
GB9604242D0 (en) * 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
DE69726182T2 (en) * 1996-12-11 2004-08-12 Dana-Farber Cancer Institute, Inc., Boston METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GROWTH PREVENTION OF TUMOR CELLS CONTAINING A PPAR-GAMMA AGONIST AND A MAP KINASE INHIBITOR
WO1998029113A1 (en) * 1996-12-31 1998-07-09 The Salk Institute For Biological Studies Treatment of disease states which result from neoplastic cell proliferation using ppar-gamma activators and compositions useful therefor
CZ302475B6 (en) * 1997-10-08 2011-06-08 Sankyo Company Limited Substituted fused heterocyclic compounds
WO2000030628A2 (en) * 1998-11-20 2000-06-02 Genentech, Inc. Method of inhibiting angiogenesis
WO2002013864A1 (en) * 2000-08-16 2002-02-21 Sankyo Company, Limited Medicinal compositions for preventing and treating cancer

Also Published As

Publication number Publication date
WO2003053440A1 (en) 2003-07-03
TW200300677A (en) 2003-06-16

Similar Documents

Publication Publication Date Title
AU2002313236A1 (en) Medicinal compositions
AU2002302147A1 (en) Pharmaceutical composition
AU2002253039A1 (en) Tramadol-based medicament
AU2002258221A1 (en) Medicinal composition
HK1065257A1 (en) Medicinal composition
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2002241114A1 (en) Composition
AU2002365093A1 (en) Therapeutic compositions
AUPR600601A0 (en) Therapeutic compositions
AU4085201A (en) Pharmaceutical composition
AU2003284460A1 (en) Medicinal composition
AU2002354460A1 (en) Medicinal composition
AU2003280799A1 (en) Medicinal composition
AU3586401A (en) Pharmaceutical composition
AU2001278705A1 (en) Pharmaceutical composition
GB0114746D0 (en) Medicinal composition
AUPR529701A0 (en) Pharmaceutical composition
AU2001282541A1 (en) Medicinal compositions
AU2003280678A1 (en) Medicinal composition
AU2002346223A1 (en) Medicinal compositions
AU2002361450A1 (en) Novel pharmaceutical
AU2002226759A1 (en) Medicinal composition
AU2002100921A4 (en) Pharmaceutical composition
AU2002335161A1 (en) Medicinal composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase